An antibody titer test is used to determine if you've had previous infections and whether or not you need certain immunizations. This test can be used to determine the following: if you need a booster shot whether you recently had or currently have an infection whether your immune system has a strong response to your own tissues, possibly indicating an autoimmune disorder whether an immunization triggers a strong enough response against the disease it's meant to protect you against
Steroids are often the first treatment for symptomatic anemia or anemia that's getting worse.
If steroids fail to work, you may need to have your spleen removed surgically. The spleen is one of the main places in your body where the destruction of RBCs occurs.
Immunosuppressant medications may be necessary if spleen removal doesn't work or is inappropriate. These drugs suppress your immune system and prevent those antibodies (proteins) from attacking your blood cells. However, immunosuppressant drugs can leave you vulnerable to infections. Some people get sick more often as a complication of this treatment. Your doctor will weigh the risks and benefits, then decide whether you should be treated with such drugs.
Medicines can improve some types of hemolytic anemia, especially autoimmune hemolytic anemia (AIHA). Corticosteroid medicines, such as prednisone, can stop your immune system from, or limit its ability to, make antibodies (proteins) against red blood cells. If you don't respond to corticosteroids, your doctor may prescribe other medicines to suppress your immune system. Examples include the medicines rituximab and cyclosporine. If you have severe sickle cell anemia, your doctor may recommend a medicine called hydroxyurea. This medicine prompts your body to make fetal hemoglobin. Fetal hemoglobin is the type of hemoglobin that newborns have. In people who have sickle cell anemia, fetal hemoglobin helps prevent red blood cells from sickling and improves anemia.
Folic acid, corticosteroids, rituximab, and IVIG. Prophylactic folic acid is indicated because active hemolysis can consume folate and cause megaloblastosis. Corticosteroids are indicated in autoimmune hemolytic anemia (AIHA). Increasing evidence supports the use of rituximab in AIHA, particularly warm antibody AIHA.